Thank you for reading the news about Coronavirus: Moderna to apply for EU's approval for Covid-19 vaccine and now with the details
Aden - Yasmine El Tohamy - Moderna said the ongoing US trial of its candidate, MRNA-1273, was on track for a data readout by November.
Moderna Inc will soon apply for real-time reviews of its experimental Covid-19 vaccine in Europe, the drug developer said on Thursday, days after the EU health regulator launched rolling reviews of shots from its rivals.
The drug developer said it was in talks with European countries and would submit the same data it plans to submit to the US Food and Drug Administration for authorisation.
The European Medicines Agency earlier this week launched real-time reviews of Covid-19 vaccines being developed by US drugmaker Pfizer and Germany's BioNTech, following a similar announcement for AstraZeneca's.
Real-time reviews could speed up the process of approving a successful vaccine, by allowing researchers to submit findings in real time, without waiting for studies to conclude.
Moderna, one of the furthest along in the US race for a Covid-19 vaccine, said the ongoing US trial of its candidate, MRNA-1273, was on track for a data readout by November.
The company said it would not enforce patents related to its experimental Covid-19 vaccine during the pandemic and would not pursue any litigation against companies that make use of its technology after the coronavirus outbreak ends.
The decision was taken allow other drugmakers to develop shots using the company's technology, Moderna executives said.
The company also said it was willing to license the technology behind the vaccine after the pandemic.
Earlier on Thursday, the Defense Advanced Research Projects Agency (DARPA) awarded Moderna $56 million to develop mobile manufacturing units for rapidly producing vaccines and therapeutics.
These were the details of the news Coronavirus: Moderna to apply for EU's approval for Covid-19 vaccine for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Khaleej Times and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
